DNTH filings
Corporate insider profile
Simon Read Filing Activity
Latest reported as Director of Dianthus Therapeutics, Inc. /DE/ (DNTH).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$630,785.64
- Latest transaction
- Aug 19, 2026
Affiliated corporations
Reported company relationships
Transaction history
